Duane Griffith, MD
Interventional Pain Medicine · Tyler, TXNPI 1023236478
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,000 of the $5,071 with a category attached, or 78.9%. Medtronic accounts for 79.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $4,255 and has fallen 97.8% since, to $92 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in TX, where the typical reported total is $6,464.
Across 27 payments — averaging $187.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$804
- Amgen$56
- Abbott$48
- AbbVie$34
- Vertiflex, Inc.$33
- plus $62 from 3 others
Across 259 payments — averaging $2800.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$712K
- Vertos Medical, Inc.$12K
- Stryker$1K
What the payments were for
- Consulting fees$64013%
- Speaking & faculty fees$4,00079%
- Food & beverage$4319%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $4,034 |
| Boston Scientific | 8 | $804 |
| Amgen | 4 | $56 |
| Abbott | 3 | $48 |
| AbbVie | 2 | $34 |
| Vertiflex, Inc. | 2 | $33 |
| Nevro Corp. | 1 | $24 |
| Novartis | 1 | $20 |
| Averitas Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$4,000
- GENERAL - THERAPIES$640
How this compares
$5,071 in reported general payments places this provider in the 40th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,537 | $40,531 |
| OxycontinOxycodone Hcl | 23 | $18,291 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 378 | $9,013 |
| Morphine Sulfate ErMorphine Sulfate | 108 | $3,455 |
| Fentanyl | 42 | $3,105 |
| Gabapentin | 129 | $1,811 |
| Morphine Sulfate | 50 | $1,610 |
| Pregabalin | 68 | $1,194 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 42 | $1,068 |
| Tramadol Hcl | 111 | $923 |
| Oxycodone Hcl | 39 | $526 |
| Methadone Hcl | 28 | $426 |
| Tizanidine Hcl | 67 | $337 |
| Amitriptyline Hcl | 16 | $214 |
| Celecoxib | 12 | $178 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Tyler
- David BowenTyler$47K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
- Bolkar SahinlerLubbock$188K
- Timothy RatinoFort Worth$139K
- Genaro GutierrezAustin$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.